Predator odor modulates auditory event-related potentials in mice

NeuroReport

Volumn 20, Issue 14, 2009, Pages 1260-1264

  Halene, Tobias B ^a,c   Talmud, Jon ^a   Jonak, Gerald J ^b   Schneider, Frank ^c   Siegel, Steven J ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ASTRAZENECA   (United Kingdom)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Auditory pathways; Event related potentials; Mice; N methyl D aspartate receptors; Olfaction; Schizophrenia

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; EVENT RELATED POTENTIAL; MALE; MOUSE; NONHUMAN; ODOR; PREDATOR; PRIORITY JOURNAL; SCHIZOPHRENIA; SMELLING;

ANIMALS; AUDITORY PERCEPTION; BRAIN; DISEASE MODELS, ANIMAL; ELECTRODES, IMPLANTED; EVOKED POTENTIALS, AUDITORY; FOXES; GENE KNOCKDOWN TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROELECTRODES; ODORS; OLFACTORY PERCEPTION; PHYSICAL STIMULATION; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 70349111501     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283300cde     Document Type: Article

References (13)

1. Apfelbach R, Blanchard CD, Blanchard RJ, Hayes RA, McGregor IS. The effects of predator odors in mammalian prey species: a review of field and laboratory studies. Neurosci Biobehav Rev 2005; 29:1123-1144.
2. Gainetdinov RR. Dopamine transporter mutant mice in experimental neuropharmacology. Naunyn Schmiedebergs arch pharmacol 2008; 377:301-313.
3. Nabeshima T, Mouri A, Murai R, Noda Y. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine. Ann N Y Acad Sci 2006; 1086:160-168.
4. Powell CM, Miyakawa T. Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol Psychiatry 2006; 59:1198-1207.
5. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999; 98:427-436.
6. Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, et al. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 2004; 153:507-519.
7. Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, et al. Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res 2008; 188:178-194.
8. Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, et al. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav 2009. [Epub ahead of print]
9. Connolly PM, Maxwell C, Liang Y, Kahn JB, Kanes SJ, Abel T, et al. The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components. Neurochem Res 2004; 29:1179-1188.
10. Maxwell CR, Ehrlichman RS, Liang Y, Gettes DR, Evans DL, Kanes SJ, et al. Corticosterone Modulates Auditory Gating in Mouse. Neuropsychopharmacology 2006; 31:897-903.
11. Moberg PJ, Arnold SE, Doty RL, Kohler C, Kanes S, Seigel S, et al. Impairment of odor hedonics in men with schizophrenia. Am J Psychiatry 2003; 160:1784-1789.
12. Mobbs D, Petrovic P, Marchant JL, Hassabis D, Weiskopf N, Seymour B et al. When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 2007; 317:1079-1083.
13. Maxwell CR, Liang Y, Weightman BD, Kanes SJ, Abel T, Gur RE, et al. Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential. Neuropsychopharmacology 2004; 29:739-746.